Vaccinated individuals less likely to develop SARS-CoV-2 anti-nucleocapsid antibodies post-infection
1. Following a SARS-CoV-2 (COVID-19) infection, patients who received the Moderna mRNA-1273 vaccine were less likely to develop anti-nucleocapsid antibodies ...